Cell-autonomous requirement of TDP-43, an ALS/FTD signature protein, for oligodendrocyte survival and myelination

被引：0
|
作者：
Ling, S-C. [1 ]
Wang, J. [1 ]
Ho, W. Y. [1 ]
Lim, K. [1 ]
Feng, J. [1 ]
Tucker-Kellogg, G. [2 ]
Nave, K-A. [3 ]
机构：
[1] Natl Univ Singapore, Physiol, Singapore, Singapore
[2] Natl Univ Singapore, Biol Sci, Singapore, Singapore
[3] Max Planck Inst Expt Med, Neurogenet, Gottingen, Germany
来源：
GLIA | 2019年 / 67卷
基金：
英国医学研究理事会;
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
T12-038B
引用
收藏
页码：E464 / E465
页数：2
相关论文
共 50 条
  • [1] Cell-autonomous requirement of TDP-43, an ALS/FTD signature protein, for oligodendrocyte survival and myelination
    Wang, Jia
    Ho, Wan Yun
    Lim, Kenneth
    Feng, Jia
    Tucker-Kellogg, Greg
    Nave, Klaus-Armin
    Ling, Shuo-Chien
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2018, 115 (46) : E10941 - E10950
  • [2] TDP-43 in FTD and ALS
    Neumann, M.
    BRAIN PATHOLOGY, 2010, 20 : 7 - 7
  • [3] Developing RNA therapeutics for TDP-43 proteinopathy in ALS/FTD
    Copley, Katie
    Smirnov, Ashleigh
    Mayne, Leland
    Wang, Yuanhang
    Black, Ben E.
    Shorter, James
    BIOPHYSICAL JOURNAL, 2024, 123 (03) : 485A - 486A
  • [4] Developing RNA Therapeutics for TDP-43 Proteinopathy in ALS/FTD
    Copley, Katie E.
    Smirnov, Ashleigh
    Shorter, James
    FASEB JOURNAL, 2022, 36
  • [5] Neuronal inclusion protein TDP-43 has no primary genetic role in FTD and ALS
    Gijselinck, I.
    Sleegers, K.
    Engelborghs, S.
    Robberecht, W.
    Martin, J. -J.
    Vandenberghe, R.
    Sciot, R.
    Dermaut, B.
    Goossens, D.
    van der Zee, J.
    De Pooter, T.
    Del-Favero, J.
    Santens, P.
    De Jonghe, P.
    De Deyn, P. P.
    Van Broeckhoven, C.
    Cruts, M.
    NEW TRENDS IN ALZHEIMER AND PARKINSON RELATED DISORDERS: ADPD 2007, 2007, : 1 - 11
  • [6] The role of FTD/ALS assciated protein, TDP-43, in neurite and synapse health and function
    Atkinson, R.
    Leung, J.
    Fernandez-Martos, C.
    Atkin, J.
    Vickers, J.
    King, A.
    JOURNAL OF NEUROCHEMISTRY, 2016, 138 : 418 - 418
  • [7] Neuronal inclusion protein TDP-43 has no primary genetic role in FTD and ALS
    Gijselinck, Ilse
    Sleegers, Kristel
    Engelborghs, Sebastiaan
    Robberecht, Wim
    Martin, Jean-Jacques
    Vandenberghe, Rik
    Sciot, Raf
    Dermaut, Bart
    Goossens, Dirk
    van der Zee, Julie
    De Pooter, Tim
    Del-Favero, Jurgen
    Santens, Patrick
    De Jonghe, Peter
    De Deyn, Peter P.
    Van Broeckhoven, Christine
    Cruts, Marc
    NEUROBIOLOGY OF AGING, 2009, 30 (08) : 1329 - 1331
  • [8] Validation of TDP-43 Splicing Repression as a Therapeutic Strategy for ALS and FTD
    Cao, Tianyu
    Mallika, Aswathy
    Sinha, Irika
    Baghel, Meghraj
    Irwin, Katie
    Ling, Jonathan
    Wong, Philip C.
    MOLECULAR THERAPY, 2024, 32 (04) : 487 - 487
  • [9] Emerging Therapies and Novel Targets for TDP-43 Proteinopathy in ALS/FTD
    Hayes, Lindsey R.
    Kalab, Petr
    NEUROTHERAPEUTICS, 2022, 19 (04) : 1061 - 1084
  • [10] Characterization of brainstem TDP-43 distribution in FTD cases with ALS features
    Scarioni, M.
    Gami-Patel, P.
    Timar, Y. S.
    Rozemuller, A. J.
    Hoozemans, J. J.
    Aronica, E.
    Raaphorst, J.
    Pijnenburg, Y. A.
    Dijkstra, A. A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 436 - 436
12345